<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Participate in Research | </title>
	<atom:link href="https://www.iths.org/participate/tag/autoimmune/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.iths.org/participate</link>
	<description>Connecting our community to health-related research opportunities</description>
	<lastBuildDate>Mon, 04 Aug 2025 15:15:24 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	
	<item>
		<title>RELIEVE, a Clinical Trial for Myasthenia Gravis</title>
		<link>https://www.iths.org/participate/relieve-a-clinical-trial-for-myasthenia-gravis/</link>
		
		<dc:creator><![CDATA[Tina Taylor]]></dc:creator>
		<pubDate>Mon, 04 Aug 2025 15:15:24 +0000</pubDate>
				<category><![CDATA[Allergies & Immune System]]></category>
		<category><![CDATA[Bones, Joints & Muscles]]></category>
		<category><![CDATA[Brain & Nervous System]]></category>
		<category><![CDATA[Eyes & Vision]]></category>
		<category><![CDATA[Acetylcholine Receptor]]></category>
		<category><![CDATA[AChR]]></category>
		<category><![CDATA[Autoimmune]]></category>
		<category><![CDATA[Bruton’s tyrosine kinase]]></category>
		<category><![CDATA[BTK inhibitor]]></category>
		<category><![CDATA[Electromyography]]></category>
		<category><![CDATA[EMG]]></category>
		<category><![CDATA[generalized Mysasthenia Gravis]]></category>
		<category><![CDATA[gMG]]></category>
		<category><![CDATA[MG]]></category>
		<category><![CDATA[Muscle-Specific Kinase]]></category>
		<category><![CDATA[MuSK]]></category>
		<category><![CDATA[Myasthenia Gravis]]></category>
		<category><![CDATA[neurology]]></category>
		<category><![CDATA[Neuromuscular]]></category>
		<category><![CDATA[Neuromuscular Junction]]></category>
		<category><![CDATA[neuroscience]]></category>
		<category><![CDATA[NMJ]]></category>
		<category><![CDATA[Rare Disease]]></category>
		<category><![CDATA[Remibrutinib]]></category>
		<category><![CDATA[seronegative MG]]></category>
		<guid isPermaLink="false">https://www.iths.org/participate/?p=5919</guid>

					<description><![CDATA[We are inviting adults aged 18-75 living with generalized Myasthenia Gravis (gMG) who are on stable standard-of-care treatment to participate in a Phase III clinical trial evaluating remibrutinib, an oral medication. RELIEVE is a clinical trial is testing the effectiveness and safety of remibrutinib for...]]></description>
		
		
		
			</item>
	</channel>
</rss>
